Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youssef A Elnabawi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Translational Andrology and Urology|November 21, 2018
Clinical implications of PET/CT in prostate cancer managementKareem N Rayn, Youssef A Elnabawi, Niki Sheth
Current Problems in Cardiology|April 22, 2026
Cardiac Dysfunction in HIV: Etiology, Pathophysiology, and Future DirectionsYoussef A Elnabawi, Farzad Marashi, Norman N Aiad, et al.
The American Journal of Cardiology|November 26, 2023
Predictors of Transthoracic Impedance in Patients Who Underwent Elective Electrical CardioversionGabriel Redel-Traub, Youssef A Elnabawi, Kursat Gurel, et al.
Journal of the American Academy of Dermatology|December 1, 2020
CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular healthYoussef A Elnabawi, Michael S Garshick, Michael Tawil, et al.
Heart Rhythm|February 26, 2026
Incidence, Predictors and Outcomes of Atrial Fibrillation and Stroke After Heart TransplantationYoussef A Elnabawi, Charlotte Lee, Geoffrey Rubin, et al.
Atherosclerosis|August 27, 2019
Serum active 1,25(OH)<sub>2</sub>D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolic and cardiovascular disease risk in psoriasisMartin P Playford, Amit K Dey, Claudia Zierold, et al.
Circulation Research|December 21, 2018
Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in PsoriasisAlexander V Sorokin, Kazuhiko Kotani, Youssef A Elnabawi, et al.
Circulation. Cardiovascular Imaging|September 15, 2020
Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core: Results From a Prospective, Observational StudyHarry Choi, Domingo E Uceda, Amit K Dey, et al.
Cardiovascular Research|February 6, 2019
Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational studyYoussef A Elnabawi, Amit K Dey, Aditya Goyal, et al.
JAMA Cardiology|August 1, 2019
Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation IndexYoussef A Elnabawi, Evangelos K Oikonomou, Amit K Dey, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Translational Andrology and Urology|November 21, 2018
Clinical implications of PET/CT in prostate cancer managementKareem N Rayn, Youssef A Elnabawi, Niki Sheth
Current Problems in Cardiology|April 22, 2026
Cardiac Dysfunction in HIV: Etiology, Pathophysiology, and Future DirectionsYoussef A Elnabawi, Farzad Marashi, Norman N Aiad, et al.
The American Journal of Cardiology|November 26, 2023
Predictors of Transthoracic Impedance in Patients Who Underwent Elective Electrical CardioversionGabriel Redel-Traub, Youssef A Elnabawi, Kursat Gurel, et al.
Journal of the American Academy of Dermatology|December 1, 2020
CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular healthYoussef A Elnabawi, Michael S Garshick, Michael Tawil, et al.
Heart Rhythm|February 26, 2026
Incidence, Predictors and Outcomes of Atrial Fibrillation and Stroke After Heart TransplantationYoussef A Elnabawi, Charlotte Lee, Geoffrey Rubin, et al.
Atherosclerosis|August 27, 2019
Serum active 1,25(OH)<sub>2</sub>D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolic and cardiovascular disease risk in psoriasisMartin P Playford, Amit K Dey, Claudia Zierold, et al.
Circulation Research|December 21, 2018
Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in PsoriasisAlexander V Sorokin, Kazuhiko Kotani, Youssef A Elnabawi, et al.
Circulation. Cardiovascular Imaging|September 15, 2020
Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core: Results From a Prospective, Observational StudyHarry Choi, Domingo E Uceda, Amit K Dey, et al.
Cardiovascular Research|February 6, 2019
Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational studyYoussef A Elnabawi, Amit K Dey, Aditya Goyal, et al.
JAMA Cardiology|August 1, 2019
Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation IndexYoussef A Elnabawi, Evangelos K Oikonomou, Amit K Dey, et al.
Pageof 2